Search results for " Major"

showing 10 items of 361 documents

The HTR1B 861GC receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy.

2000

Abstract The HTR1B receptor gene has been linked to antisocial alcoholism in a Finnish population and an American Indian tribe [Lappalainen et al., Arch. Gen. Psychiatry, 55 (1998) 989]. Using a candidate gene approach, we genotyped 209 patients with alcoholism, 108 patients with major depression, 32 patients with panic disorder, 50 patients with generalized anxiety disorder, 58 patients with narcolepsy and 74 healthy volunteers for the HTR1B 861G>C polymorphism. There was a higher frequency of the HTR1B 861G alleles among the alcohol-dependent patients as compared to the control subjects (χ 2 =4.02, d.f.=2, P =0.04). However, the association resulted from higher frequencies of the opposite…

AdultMaleRiskCandidate genemedicine.medical_specialtyGeneralized anxiety disorderGenotypeInternal medicineGermanymedicineHumansPsychiatryTemperamentBiological PsychiatryPsychiatric geneticsAllelesNarcolepsyDepressive Disorder MajorPolymorphism GeneticPanic disorderPanicmedicine.diseaseAnxiety DisordersPsychiatry and Mental healthAlcoholismPhenotypeCase-Control StudiesReceptors SerotoninReceptor Serotonin 5-HT1BAnxietyPanic DisorderChromosomes Human Pair 6Femalemedicine.symptomPsychologyAnxiety disorderNarcolepsyPsychiatry research
researchProduct

Self-compassion as an emotion regulation strategy in major depressive disorder

2013

Cognitive reappraisal and acceptance are two presumably adaptive emotion regulation strategies in depression. More recently, self-compassion has been discussed as another potentially effective strategy for coping with depression. In the present study, we compared the effectiveness of self-compassion with a waiting condition, reappraisal, and acceptance in a clinically depressed sample, and tested the hypothesis that the intensity of depressed mood would moderate the differential efficacy of these strategies. In an experimental design, we induced depressed mood at four points in time in 48 participants meeting criteria for major depressive disorder. After each mood induction, participants we…

AdultMaleSelf-AssessmentCoping (psychology)animal structuresAdolescentEmotionsExperimental and Cognitive PsychologyCognitive reappraisalYoung AdultCognitionAdaptation Psychologicalmental disordersmedicineHumansIn patientDepressive Disorder MajorMiddle Agedmedicine.diseaseSelf ConceptPsychiatry and Mental healthClinical PsychologyMoodMood inductionMajor depressive disorderFemaleSelf ReportEmpathyDepressed moodPsychologySelf-compassionClinical psychologyBehaviour Research and Therapy
researchProduct

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depr…

2004

The catechol-O-methyltransferase (COMT) is a major degrading enzyme in the metabolic pathways of catecholaminergic neurotransmitters such as dopamine and norepinephrine. This study investigated whether the functionally relevant Val(108/158)Met gene variant is associated with differential antidepressant response to mirtazapine and/or paroxetine in 102 patients with major depression (DSM-IV criteria) participating in a randomized clinical trial with both drugs. In patients treated with mirtazapine, but not paroxetine, allelic variations in the COMT gene were associated with differential response. COMT(VAL/VAL) and COMT(VAL/MET) genotype carriers showed a better response than COMT(MET/MET)-bea…

AdultMaleTime FactorsMirtazapineMirtazapineMianserinPharmacologyCatechol O-Methyltransferaselaw.inventionMethionineRandomized controlled triallawDopamineGenotypeGeneticsmedicineHumansPharmacologyDepressive Disorder MajorCatechol-O-methyl transferasePolymorphism Geneticbusiness.industryHamilton Rating Scale for DepressionValineMiddle AgedParoxetineParoxetineMolecular MedicineAntidepressantFemalebusinessmedicine.drugThe pharmacogenomics journal
researchProduct

Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia

2006

Adult thalassemic patients have reduced bone mass due to disturbances in several different mechanisms affecting bone turnover. To determine if vitamin D deficiency contributes to the low bone mass of adult thalassemic subjects, we studied serum 25-OH-vitamin D levels in 90 patients (age ranging between 21 and 48 years) affected with thalassemia major (TM) and 35 (age 21-56 years) with thalassemia intermedia (TI). TM patients had been receiving regular transfusions from the age of 2 years and had increased serum ferritin, glutamic oxalacetic transaminase, glutamic piruvic transaminase as well as low bone density (L1-L4 Z score -2.07 +/- 0.2). TI patients did not receive transfusions, but the…

AdultMaleVitaminmedicine.medical_specialtyHistologyBone densityPhysiologyEndocrinology Diabetes and MetabolismThalassemiavitamin D deficiencyTransaminaseBone remodelingchemistry.chemical_compoundBone DensityInternal medicineVitamin D and neurologyHumansMedicineVitamin DThalassemia majorbusiness.industryMiddle Agedmedicine.diseaseUrinary calciumEndocrinologychemistryParathyroid HormoneThalassemiaFemalebusinessBone
researchProduct

Adherence predictors in an Internet-based Intervention program for depression

2017

Internet-delivered psychotherapy has been demonstrated to be effective in the treatment of depression. Nevertheless, the study of the adherence in this type of the treatment reported divergent results. The main objective of this study is to analyze predictors of adherence in a primary care Internet-based intervention for depression in Spain. A multi-center, three arm, parallel, randomized controlled trial was conducted with 194 depressive patients, who were allocated in self-guided or supported-guided intervention. Sociodemographic and clinical characteristics were gathered using a case report form. The Mini international neuropsychiatric interview diagnoses major depression. Beck Depressio…

AdultMalemedicine.medical_specialtyAdolescent020205 medical informaticsPsychological intervention02 engineering and technologylaw.inventionprimary careYoung Adult03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifelawIntervention (counseling)0202 electrical engineering electronic engineering information engineeringHumansMedicineadherencePsychiatryCase report formDepression (differential diagnoses)AgedMini-international neuropsychiatric interviewPsychiatric Status Rating ScalesDepressive Disorder MajorInternetPrimary Health Carebusiness.industryBeck Depression InventoryMiddle AgedInternet-based intervention030227 psychiatryPsychotherapyClinical PsychologyTherapy Computer-AssisteddepressionQuality of LifePatient ComplianceFemalebusinessClinical psychologyCognitive Behaviour Therapy
researchProduct

Clinical features and epidemiology of cutaneous leishmaniasis and Leishmania major/HIV co-infection in Cameroon: results of a large cross-sectional s…

2011

Cutaneous leishmaniasis (CL) is endemic in Central Africa, including Cameroon. However, data on its prevalence and co-infection with HIV are scarce. Here we present the results of a large cross-sectional study reporting the prevalence, clinical features and species identification of CL and HIV co-infection in northern Cameroon. A total of 32 466 subjects were clinically screened for CL during a door-to-door survey, followed by parasitological diagnosis in the field laboratory. Amongst the subjects surveyed, 146 (0.4%) were diagnosed with active CL. Seven (4.8%) of these 146 CL patients tested positive for HIV-1 and/or HIV-2. The number of lesions per CL patient ranged from 1 to 20. Three of…

AdultMalemedicine.medical_specialtyAdolescentCross-sectional studyAIDS-Related Opportunistic InfectionsAntiprotozoal AgentsLeishmaniasis CutaneousPolymerase Chain ReactionYoung AdultCutaneous leishmaniasisInternal medicineEpidemiologyHIV SeropositivitymedicineHumansLeishmania majorCameroonYoung adultChildAgedLeishmania majorbiologyAIDS-Related Opportunistic Infectionsbusiness.industryPublic healthPublic Health Environmental and Occupational Healthvirus diseasesInfantGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationVirologyInfectious DiseasesCross-Sectional StudiesChild PreschoolHIV-2CoinfectionHIV-1ParasitologyFemalePublic HealthbusinessTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Multiple lifestyle factors and depressed mood: a cross-sectional and longitudinal analysis of the UK Biobank (N = 84,860)

2020

Abstract Background There is now evolving data exploring the relationship between depression and various individual lifestyle factors such as diet, physical activity, sleep, alcohol intake, and tobacco smoking. While this data is compelling, there is a paucity of longitudinal research examining how multiple lifestyle factors relate to depressed mood, and how these relations may differ in individuals with major depressive disorder (MDD) and those without a depressive disorder, as ‘healthy controls’ (HC). Methods To this end, we assessed the relationships between 6 key lifestyle factors (measured via self-report) and depressed mood (measured via a relevant item from the Patient Health Questio…

AdultMalemedicine.medical_specialtyAdolescentExacerbationlcsh:Medicinebehavioral disciplines and activitiesYoung Adult03 medical and health sciencesScreen time0302 clinical medicineInternal medicinemental disordersmedicineLifestyle medicineHumansLife StyleLifestyle medicineDepression (differential diagnoses)Biological Specimen BanksDepressive Disorder MajorPhysical activitybusiness.industrylcsh:RGeneral Medicinemedicine.diseaseMental healthUnited KingdomScreen timeDiet030227 psychiatryPatient Health QuestionnaireCross-Sectional StudiesDiet Health Lifestyle medicine Mood disorders Physical activity Screen time Adolescent Adult Biological Specimen Banks Cross-Sectional Studies Depressive Disorder Major Female Humans Male United Kingdom Young Adult Life StyleMood disordersHealthMood disordersMajor depressive disorderFemalebusiness030217 neurology & neurosurgeryResearch Article
researchProduct

Adaptation and validation of the Patient Health Questionnaire-9 to evaluate major depression in a primary care sample in Latvia

2017

Background: Depression is one of the most common mental disorders in primary care settings and is often underdiagnosed and undertreated by general practitioners (GPs). To date, no depression screening instruments have been validated for use in primary care settings in Latvia. The aim of this study was to establish the validity and cutoff score of the Patient Health Questionnaire-9 (PHQ-9) among primary care patients in Latvia. Materials and methods: During a one-week period, all consecutive patients aged 18 years or older visiting their GP of health concerns at 6 primary care settings were invited to complete the PHQ-9 questionnaire in their native language (Latvian or Russian). Criterion v…

AdultMalemedicine.medical_specialtyAdolescentPrimary health careSample (statistics)Primary carePatient Health QuestionnaireSensitivity and SpecificityYoung Adult03 medical and health sciences0302 clinical medicinemedicineHumansMass ScreeningTranslations030212 general & internal medicineYoung adultPsychiatryMass screeningDepression (differential diagnoses)AgedAged 80 and overDepressive Disorder MajorPrimary Health Carebusiness.industryReproducibility of ResultsMiddle AgedLatviaPatient Health QuestionnairePsychiatry and Mental healthFemaleDepression screenbusiness030217 neurology & neurosurgery
researchProduct

Experimental evidence for a motivational origin of cognitive impairment in major depression.

2007

BackgroundDiagnostic criteria and empirical evidence support the existence of cognitive deficits in depression. However, depressed mood, loss of interest and low self-efficacy might influence cognitive performance.MethodGoal-setting instructions were used to promote motivation in depressed patients and control subjects during neuropsychological assessment. The resulting performance was compared with performance using standard instructions. Sixty in-patients with non-psychotic unipolar depression and 60 age- and education-matched healthy control subjects were assessed with standard neuropsychological tests [the Auditory Verbal Learning Test (AVLT), the Digit Symbol Test (DST), the Regensburg…

AdultMalemedicine.medical_specialtyAudiologyNeuropsychological TestsVerbal learningSeverity of Illness IndexSurveys and QuestionnairesmedicinePrevalenceVerbal fluency testHumansNeuropsychological assessmentPsychiatryApplied PsychologyDepression (differential diagnoses)Psychomotor learningDepressive Disorder MajorMotivationmedicine.diagnostic_testCognitive disorderNeuropsychologyCognitionVerbal Learningmedicine.diseaseSelf EfficacyPsychiatry and Mental healthFemalePsychomotor DisordersPsychologyCognition DisordersGoalsPsychological medicine
researchProduct

Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study.

2020

Aim We aimed to identify whether lifetime cocaine use is a risk factor for conversion from major depressive disorder (MDD) to bipolar disorder (BD) in an outpatient sample of adults. Methods This prospective cohort study included 585 subjects aged 18 to 60 years who had been diagnosed with MDD as assessed by the Mini International Neuropsychiatric Interview (MINI-Plus) at baseline (2012-2015). Subjects were reassessed a mean of 3 years later (2017-2018) for potential conversion to BD as assessed by the MINI-Plus. Lifetime cocaine use was assessed using the Alcohol, Smoking, and Substance Involvement Screening Test. Results In the second wave, we had 117 (20%) losses, and 468 patients were r…

AdultMalemedicine.medical_specialtyBipolar DisorderAdolescentPoison control03 medical and health sciencesCocaine-Related DisordersYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansBipolar disorderProspective StudiesRisk factorProspective cohort studyMini-international neuropsychiatric interviewDepressive Disorder Majorbusiness.industryGeneral NeuroscienceGeneral MedicineMiddle Agedmedicine.diseaseConfidence interval030227 psychiatryPsychiatry and Mental healthNeurologyCohortDisease ProgressionMajor depressive disorderFemaleNeurology (clinical)business030217 neurology & neurosurgeryPsychiatry and clinical neurosciencesReferences
researchProduct